A recent study indicates that the oncogenic action in colon cancer is linked to an induction of a DNA helicase (CHD1L) and inhibition of E3 ubiquitin ligase HERC2-mediated p53 degradation [28]. The gene discussed is TP53; the disease is colonic neoplasm.